These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10686795)

  • 1. [Clinical case of the month. Mental confusion due to the administration of tramadol in a patient treated with MOAI].
    Calvisi V; Ansseau M
    Rev Med Liege; 1999 Dec; 54(12):912-3. PubMed ID: 10686795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe use of remifentanil in a patient treated with the monoamine oxidase inhibitor phenelzine.
    Ure DS; Gillies MA; James KS
    Br J Anaesth; 2000 Mar; 84(3):414-6. PubMed ID: 10793610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response.
    Heydendael W; Jacobson L
    Brain Res; 2008 Oct; 1238():93-107. PubMed ID: 18761333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do monoamine oxidase inhibitors alter carbamazepine blood levels?
    Barklage NE; Jefferson JW; Margolis D
    J Clin Psychiatry; 1992 Jul; 53(7):258. PubMed ID: 1639748
    [No Abstract]   [Full Text] [Related]  

  • 8. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neglected modality in psychiatric treatment--the monoamine oxidase inhibitors.
    Johnson WC
    Dis Nerv Syst; 1975 Sep; 36(9):521-5. PubMed ID: 1175468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.
    Kier A; Han J; Jacobson L
    Endocrinology; 2005 Mar; 146(3):1338-47. PubMed ID: 15564336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?
    Park SH; Wackernah RC; Stimmel GL
    J Pharm Pract; 2014 Feb; 27(1):71-8. PubMed ID: 24153222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between catecholamines and tricyclic and monoamine oxidase inhibitor antidepressive agents in man.
    Barar FS; Boakes AJ; Benedikter LB; Laurence DR; Prichard BN; Teoh PC
    Br J Pharmacol; 1971 Oct; 43(2):472P-473P. PubMed ID: 5158242
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of pharmacological activity and toxicity of the antidepressants nialamide, phenelzine and iproniazide].
    Lapin IP; Samsonova ML
    Farmakol Toksikol; 1969; 32(5):526-30. PubMed ID: 5364661
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes.
    Chiche F; Le Guillou M; Chétrite G; Lasnier F; Dugail I; Carpéné C; Moldes M; Fève B
    Mol Pharmacol; 2009 May; 75(5):1052-61. PubMed ID: 19201819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.